Viridian Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 25.0 | 17.3 | 48.1 | 97.8 | 55.6 | 57.9 | 22.3 | 19.8 | 18.9 | 11.0 | 21.8 | 15.1 | 5.6 | 3.5 | 4.2 | 22.7 | 23.2 | 61.8 | 63.2 | 57.2 | 65.8 | 74.7 | 279.7 | 360.2 | 367.7 | 668.1 | 648.7 | 700.3 | 1,924.8 | 3,449.2 | 3,712.6 | 2,882.3 | 5,014.5 | 5,089.4 | 3,636.2 | 3,745.3 | 25.0 | 37.2 | 28.2 | 27.9 | |
| 17.3 | – | 3.0 | 6.7 | 5.1 | 6.0 | 2.5 | 2.9 | 2.8 | 1.8 | 2.1 | 1.9 | 1.0 | 1.0 | 0.8 | 2.8 | 2.1 | 0.5 | 1.0 | 1.5 | 0.9 | 1.2 | 2.9 | 2.3 | 1.7 | 3.0 | 3.1 | 3.3 | 2.4 | 2.5 | 1.8 | 1.6 | 2.1 | 2.3 | 1.8 | 2.2 | 3.5 | 3.7 | 3.1 | 3.0 | |
| 23.7 | 16.6 | 30.5 | 82.1 | 44.2 | – | – | 15.4 | 15.6 | 7.4 | 18.0 | 10.5 | 0.4 | -0.2 | -1.6 | 14.4 | 12.1 | 18.5 | 35.7 | 46.7 | 16.4 | 60.6 | 262.2 | 331.0 | 187.5 | 583.2 | 598.4 | 644.8 | 1,663.2 | 3,188.8 | 3,466.0 | 2,581.2 | 4,421.1 | 4,829.5 | 3,321.7 | 3,430.6 | 22.9 | 34.9 | 26.5 | 29.0 | |
| -8.4% | -12.8% | -9.3% | -6.7% | -11.6% | -12.3% | -14.9% | -12.9% | -15.3% | -29.5% | -36.6% | -52.7% | -161.1% | -232.5% | -160.0% | -55.4% | -64.8% | -45.9% | -31.1% | -27.5% | -25.8% | -24.8% | -13.4% | -21.2% | -11.1% | -8.0% | -12.6% | -15.8% | -27.1% | -17.1% | -15.7% | -20.3% | -13.0% | -15.1% | -25.5% | -27.1% | -18.5% | -10.5% | -15.2% | -16.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 28.6% | 23.6% | -102.6% | -285.8% | -329.4% | -390.2% | -163.3% | -153.4% | -198.7% | -262.8% | -724.3% | -666.0% | -753.1% | -635.1% | -389.0% | -500.7% | -407.9% | -1,649.0% | -1,823.0% | -1,623.9% | -1,674.7% | -1,819.9% | -3,420.0% | -7,727.0% | -4,364.2% | -5,593.8% | -4,927.1% | -4,079.3% | -11,230.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.5% | 99.5% | 99.6% | |
| -308.4% | -374.8% | -560.6% | -763.8% | -719.1% | -662.8% | -290.8% | -262.8% | -318.4% | -394.5% | -1,011.6% | -935.5% | -1,044.1% | -941.0% | -777.7% | -1,387.5% | -1,591.3% | -10,512.4% | -7,226.4% | -5,106.8% | -5,039.1% | -2,690.8% | -5,040.6% | -11,036.7% | -6,077.6% | -7,579.2% | -10,936.4% | -14,326.5% | -66,869.7% | -81,035.0% | -82,595.1% | -87,078.5% | -93,722.5% | -99,018.5% | -111,591.1% | -121,831.1% | -463.5% | -512.9% | -543.9% | -569.7% | |
| -311.2% | -379.8% | -566.8% | -768.2% | -720.4% | -662.3% | -290.6% | -261.5% | -316.1% | -390.0% | -998.3% | -925.5% | -1,037.0% | -938.6% | -778.7% | -1,393.5% | -1,604.0% | -10,544.3% | -7,240.3% | -5,112.1% | -5,037.8% | -2,680.2% | -5,014.2% | -10,981.3% | -6,009.3% | -7,329.2% | -10,419.1% | -13,462.9% | -62,437.8% | -75,711.5% | -75,737.8% | -79,185.8% | -85,127.2% | -89,387.1% | -102,092.4% | -112,806.9% | -426.6% | -483.6% | -508.5% | -544.1% | |
| -210.3% | -221.1% | -448.9% | -652.9% | -645.4% | -709.8% | -332.0% | -256.0% | -289.4% | -325.4% | -797.2% | -796.2% | -901.2% | -810.1% | -666.1% | -1,257.7% | -1,503.3% | -2,836.1% | -1,965.0% | -1,571.1% | -1,701.1% | -1,853.5% | -3,737.6% | -7,637.5% | -4,092.6% | -5,340.6% | -8,192.4% | -11,065.9% | -52,245.8% | -58,938.9% | -58,403.8% | -58,618.1% | -65,374.8% | -77,096.0% | -92,829.8% | -101,507.9% | -461.0% | -390.8% | -428.4% | -471.0% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -215.2% | – | -35.2% | -52.5% | -65.9% | -68.8% | -33.3% | -37.8% | -47.4% | -63.7% | -96.9% | -119.2% | -181.6% | -265.8% | -141.8% | -169.2% | -143.0% | -92.2% | -114.3% | -134.1% | -69.0% | -42.3% | -52.0% | -69.2% | -27.6% | -32.9% | -49.2% | -62.7% | -76.4% | -53.8% | -37.4% | -43.1% | -36.3% | -40.2% | -51.0% | -66.8% | -60.0% | -47.4% | -56.7% | -58.4% | |
| -133.7% | -297.6% | -29.2% | -43.4% | -54.6% | -50.5% | -27.8% | -31.3% | -37.6% | -49.4% | -72.2% | -81.7% | -108.4% | -138.4% | -98.0% | -107.0% | -91.6% | -84.4% | -98.6% | -112.2% | -63.8% | -39.0% | -47.3% | -57.8% | -25.7% | -29.8% | -44.6% | -56.3% | -65.9% | -48.5% | -34.6% | -38.9% | -33.3% | -36.4% | -46.6% | -59.1% | -52.3% | -38.1% | -45.7% | -35.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -4.2 | -2.3 | -52 | -44 | -41 | – | – | -43 | -30 | -30 | -15 | -20 | -21 | -17 | -28 | -21 | -21 | -45 | -46 | -27 | -138 | -42 | -30 | -26 | -339 | -150 | -83 | -82 | -91 | -82 | -71 | -87 | -179 | -78 | -95 | -96 | -148 | -162 | -125 | 78 | |
| 62.1% | -7.7% | 83.0% | 82.6% | 82.8% | 73.4% | 83.6% | 82.6% | 79.3% | 77.6% | 74.5% | 68.5% | 59.7% | 52.1% | 69.1% | 63.2% | 64.1% | 91.5% | 86.3% | 83.7% | 92.5% | 92.1% | 91.0% | 83.6% | 92.8% | 90.8% | 90.7% | 89.9% | 86.3% | 90.1% | 92.4% | 90.4% | 91.7% | 90.5% | 91.5% | 88.5% | 87.1% | 80.3% | 80.6% | 60.3% | |
| 0.2 | – | 0.0 | 0.0 | 0.1 | – | – | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.5 | 0.3 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.4 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -14.02 | -16.45 | -21.93 | -15.20 | -17.87 | -17.84 | -13.70 | -12.67 | -14.05 | -15.91 | -19.27 | -19.29 | -20.30 | -19.40 | -12.63 | -10.12 | -8.09 | -28.15 | -19.12 | -16.36 | -12.63 | -7.10 | -3.32 | -3.54 | -3.35 | -3.20 | -4.08 | -4.58 | -4.96 | -4.79 | -3.57 | -3.57 | -3.87 | -3.37 | -3.79 | -4.22 | -3.69 | -4.04 | -3.53 | -3.59 | |
| 4.51 | 4.33 | 3.87 | 1.98 | 2.48 | 2.69 | 4.72 | 4.85 | 4.44 | 4.08 | 1.93 | 2.08 | 1.96 | 2.07 | 1.62 | 0.73 | 0.50 | 0.27 | 0.26 | 0.32 | 0.25 | 0.26 | 0.07 | 0.03 | 0.06 | 0.04 | 0.04 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.87 | 0.84 | 0.69 | 0.66 | |
| 6.52 | -0.42 | 62.30 | 28.96 | 27.11 | 25.91 | 41.18 | 33.51 | 29.64 | 24.97 | 19.89 | 16.19 | 11.18 | 7.30 | 8.91 | 5.98 | 5.66 | 30.52 | 16.73 | 12.20 | 18.29 | 16.78 | 6.38 | 5.11 | 12.12 | 9.74 | 8.30 | 7.30 | 6.50 | 8.90 | 9.53 | 8.29 | 10.65 | 8.39 | 7.43 | 6.31 | 6.15 | 8.52 | 6.22 | 6.14 | |
| -9.47 | -9.58 | -17.37 | -12.92 | -16.01 | -19.11 | -15.66 | -12.41 | -12.86 | -13.27 | -15.39 | -16.60 | -17.64 | -16.74 | -10.80 | -9.14 | -7.58 | -7.57 | -5.19 | -5.03 | -4.26 | -4.91 | -2.47 | -2.46 | -2.28 | -2.33 | -3.21 | -3.76 | -4.15 | -3.73 | -2.75 | -2.64 | -2.97 | -2.91 | -3.45 | -3.79 | -3.99 | -3.27 | -2.97 | -3.11 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.